| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |